These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 32198977)

  • 41. Vitiligo: a manifestation of apoptosis?
    Huang CL; Nordlund JJ; Boissy R
    Am J Clin Dermatol; 2002; 3(5):301-8. PubMed ID: 12069635
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vitiligo: advances in pathophysiology research and treatment development.
    Mukhatayev Z; Le Poole IC
    Trends Mol Med; 2024 Sep; 30(9):844-862. PubMed ID: 38705825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Repigmentation by combined narrow‑band ultraviolet B/adipose‑derived stem cell transplantation in the mouse model: Role of Nrf2/HO‑1‑mediated Ca
    Bian Y; Yu H; Jin M; Gao X
    Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34751412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emerging Role of Fibroblasts in Vitiligo: A Formerly Underestimated Rising Star.
    Wu Y; Yang Y; Lin Y; Ding Y; Liu Z; Xiang L; Picardo M; Zhang C
    J Invest Dermatol; 2024 Aug; 144(8):1696-1706. PubMed ID: 38493384
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoimmune aspects of depigmentation in vitiligo.
    Le Poole IC; Wañkowicz-Kaliñska A; van den Wijngaard RM; Nickoloff BJ; Das PK
    J Investig Dermatol Symp Proc; 2004 Jan; 9(1):68-72. PubMed ID: 14870989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Perspectives of New Advances in the Pathogenesis of Vitiligo: From Oxidative Stress to Autoimmunity.
    Wang Y; Li S; Li C
    Med Sci Monit; 2019 Feb; 25():1017-1023. PubMed ID: 30723188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repigmentation of vitiligo-associated leukotrichia after autologous, non-cultured melanocyte-keratinocyte transplantation.
    Al Jasser MI; Ghwish B; Al Issa A; Mulekar SV
    Int J Dermatol; 2013 Nov; 52(11):1383-6. PubMed ID: 23834588
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Understanding mechanisms of autoimmunity through translational research in vitiligo.
    Strassner JP; Harris JE
    Curr Opin Immunol; 2016 Dec; 43():81-88. PubMed ID: 27764715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes.
    Shajil EM; Chatterjee S; Agrawal D; Bagchi T; Begum R
    Indian J Exp Biol; 2006 Jul; 44(7):526-39. PubMed ID: 16872041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of aryl hydrocarbon receptor in vitiligo: a review.
    Li Y; Zeng Y; Chen Z; Tan X; Mei X; Wu Z
    Front Immunol; 2024; 15():1291556. PubMed ID: 38361944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitiligo: current medical and scientific understanding.
    Boissy RE; Nordlund JJ
    G Ital Dermatol Venereol; 2011 Feb; 146(1):69-75. PubMed ID: 21317859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Update on the pathogenesis of vitiligo.
    Marchioro HZ; Silva de Castro CC; Fava VM; Sakiyama PH; Dellatorre G; Miot HA
    An Bras Dermatol; 2022; 97(4):478-490. PubMed ID: 35643735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current Status of Cell-Based Therapies for Vitiligo.
    Domaszewska-Szostek A; Polak A; Słupecka-Ziemilska M; Krzyżanowska M; Puzianowska-Kuźnicka M
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo.
    Webb KC; Eby JM; Hariharan V; Hernandez C; Luiten RM; Le Poole IC
    Exp Dermatol; 2014 Aug; 23(8):529-33. PubMed ID: 24840876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apoptosis of melanocytes in vitiligo results from antibody penetration.
    Ruiz-Argüelles A; Brito GJ; Reyes-Izquierdo P; Pérez-Romano B; Sánchez-Sosa S
    J Autoimmun; 2007 Dec; 29(4):281-6. PubMed ID: 17888626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dysfunction of Autophagy: A Possible Mechanism Involved in the Pathogenesis of Vitiligo by Breaking the Redox Balance of Melanocytes.
    Qiao Z; Wang X; Xiang L; Zhang C
    Oxid Med Cell Longev; 2016; 2016():3401570. PubMed ID: 28018522
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regenerative Medicine-Based Treatment for Vitiligo: An Overview.
    Bellei B; Papaccio F; Picardo M
    Biomedicines; 2022 Oct; 10(11):. PubMed ID: 36359263
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vitiligo: Pathogenesis, clinical variants and treatment approaches.
    Iannella G; Greco A; Didona D; Didona B; Granata G; Manno A; Pasquariello B; Magliulo G
    Autoimmun Rev; 2016 Apr; 15(4):335-43. PubMed ID: 26724277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxidative Stress-Induced HMGB1 Release from Melanocytes: A Paracrine Mechanism Underlying the Cutaneous Inflammation in Vitiligo.
    Cui T; Zhang W; Li S; Chen X; Chang Y; Yi X; Kang P; Yang Y; Chen J; Liu L; Jian Z; Li K; Wang G; Gao T; Song P; Li C
    J Invest Dermatol; 2019 Oct; 139(10):2174-2184.e4. PubMed ID: 30998983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Premature cell senescence in human skin: Dual face in chronic acquired pigmentary disorders.
    Bellei B; Picardo M
    Ageing Res Rev; 2020 Jan; 57():100981. PubMed ID: 31733332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.